Acute cardiac care & resuscitation

Guideline-Directed Medical Therapy Implementation During Hospitalization for Cardiogenic Shock

ESC Heart FailPublished Retrospective cohort study

Authors' conclusion

Most patients who survived CS admission with HFrEF in this single-centre CS registry were not prescribed all classes or goal doses of GDMT at hospital discharge.

Study context

Population
Patients surviving hospitalization for cardiogenic shock with HFrEF, Inova single-centre shock registry, January 2017 to December 2019of 520 cardiogenic shock (CS) patients
Participants
185 patients
Exposure
Guideline-directed medical therapy (GDMT) utilization at discharge in CS survivors with HFrEF
Outcome
Use of GDMT during CS admission and short-term outcomes
Methodological detailssingle-centre, registry, Data collected by retrospective chart review
  • Single-centre
  • Registry
  • Data collected by retrospective chart review

Main finding

As reported in the abstract

GDMT at discharge
Beta-blockers
78% (n = 144)
ACEi/ARB/ARNI
58% (n = 107)
MRA
55% (n = 101)
Three-drug GDMT
33.0% (n = 61)
No GDMT component prescribed
Ten per cent (n = 19)

Observational data: associations, not effects.

Further findings

OutcomeOdds of survival (CI)P value
Survival with ≥1 additional GDMT class added during admission vs none · 6 months and 1 year≥1 GDMT class added vs No GDMT added · 6 month survival7.1 (1.9–28.5)P < 0.01
Survival with ≥1 additional GDMT class added during admission vs none · 6 months and 1 year≥1 GDMT class added vs No GDMT added · 1 year survival6.0 (1.9–20.5)P < 0.01

Predictors of GDMT addition (multivariable logistic regression adjusted for baseline GDMT)

Lower left ventricular ejection fraction (LVEF) and transfer from an outside hospital associated with GDMT addition
P < 0.05

Length of hospital stay

Median length of stay 12 days
IQR 7, 18

Original publication

Guideline-Directed Medical Therapy Implementation During Hospitalization for Cardiogenic Shock. ESC Heart Fail. Published 26 September 2024. doi:10.1002/ehf2.14863

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.